RPS6P15

Across TCGA pan-cancer cohorts, RPS6P15 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS6P15’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RPS6P15 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS6P15 is over-expressed in tumor, although a few such as HNSC and STAD show the opposite, repressed pattern.

HNSC and STAD are the cancer types where RPS6P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS6P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	−0.072	.008	6	view →
STAD	Male	III,IV	−0.145	.011	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPS6P15–HNSC

Open the HNSC breakdown →